Jump To Main Content Jump To Main Navigation Jump To Footer

 

About us

 

 

 

 

 

 

One team - one mission

Our interdisciplinary team combines expertise in biosignal engineering, software and hardware development, and clinical and regulatory affairs.

With years of experience at leading companies and research institutions, we are committed to developing innovative medical devices that improve patient care.

Our Medical Board provides expert guidance and support for our engineering projects and clinical studies.

Shaping the future of brain monitoring

Sonovum develops innovative medical devices for non-invasive brain monitoring. The UltraEASY 3 medical device, classified as class IIa under MDD, enables ultrasound-based recording* of the brain pulse curve. This biosignal is used in various fields of research to classify and monitor neurological conditions.

The successor to the UltraEASY 3L, TTUS in TBI®, is currently undergoing clinical trials. This is the first medical device to non-invasively classify intracranial pressure, with a planned release in 2025.

*Transcranial transmission ultrasound, TTUS®

Partnering for innovation in patient care

Sonovum collaborates with a network of strong partners to drive innovation in medical technology and provide patients with the best possible care.

This includes start-up and MedTech platforms that promote the exchange of expertise and experience. Our suppliers provide high-quality, state-of-the-art hardware components for our medical products, while we develop application-oriented solutions through research collaborations with Fraunhofer Institutes and technical universities.

Certificates

We are an ISO 13485 certified medical technology manufacturer, ensuring the highest quality and safety standards for our devices. All our medical devices bear the CE mark, demonstrating compliance with European Union regulations.

Download our certificates here.

ISO 13485 -Certificate

Download PDF

CE-Certificate UltraEASY 3 and 3L

Download PDF